DRD3 and myeloid sarcoma: Although dopaminergic signalling through DRD3, which displays the highest affinity for dopamine, has been strongly associated with the development and progression of inflammatory disorders [10, 12, 14, 15, 26], the involvement of this receptor in the physiopathology of MS/EAE remains poorly explored.